Other Science
476 articles
Studying One Family’s Mutations May Change Pancreatic Cancer Treatment and Prevention
Dr. Sahar Nissim is studying the genetic mutations in one family predisposed to pancreatic cancer, to find new ways to combat the disease.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients
Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.
New Study Combines Checkpoint Inhibitors with Radiation Therapy to Boost Immune Response
Dr. Theodore Hong combines checkpoint inhibitors–a type of immunotherapy–with radiation to boost the immune system in pancreatic cancer treatment.
Eating Right Can Help Your Pancreatic Cancer Fight
Pancreatic cancer patients can potentially combat side effects of treatment through a proper diet, according to advice from oncology dietitian Maria Petzel.
New Study Focuses On Supportive Oncology Care At Home
Dr. Ryan Nipp is exploring the value of supportive oncology care at home for pancreatic cancer patients in a pilot clinical trial.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.
What You Should Know About Pancreatic Cysts
Dr. V. Raman Muthusamy explains the difference between pancreatic cysts and pancreatic cancer. Learn about different types of pancreatic cysts and which may develop cancer.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients
Genetics impact your treatment for pancreatic cancer. Dr. Sapna Syngal discusses the recommendation of genetic testing for all pancreatic cancer patients.
Which Is the Best Screening Method for Pancreatic Cancer?
Dr. Aimee Lucas outlines the pros and cons of various screening methods that can be used for pancreatic cancer, and who should be using them.
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
New Research Sheds Light on Hot and Cold Tumors
Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.